WeVote
Log In

Bill

Bill

SD 1412

An Act to clarify prescription monitoring program activities

194th Legislature (2025-2026) Introduced by Will Brownsberger and 1 co-sponsor

Massachusetts bill clarifies prescription monitoring program rules to better track controlled substance prescriptions and prevent drug diversion.

House concurred
0
WeVote Research Nonpartisan
Bill Summary · SD 1412

Legislative bill overview

SD 1412 clarifies the scope and operations of Massachusetts' Prescription Monitoring Program (PMP), which tracks controlled substance prescriptions to prevent drug abuse and diversion. The bill refines how the state's PMP functions, though the specific clarifications are not detailed in the available legislative record.

Why is this important

Prescription monitoring programs are a key public health tool for combating the opioid crisis and reducing prescription drug abuse by identifying doctor shopping and overprescribing patterns. Clear statutory language ensures healthcare providers and pharmacists understand their obligations and helps the program operate consistently across the state.

Potential points of contention

  • Provider burden vs. oversight balance: Clarifications about PMP activities may either expand requirements on prescribers/pharmacists (potentially creating administrative burden) or limit oversight (potentially reducing effectiveness at catching problematic prescribing)
  • Patient privacy concerns: PMP data involves sensitive health information; clarifications about data access, retention, or sharing could affect how strictly patient information is protected
  • Scope of controlled substances: The bill may clarify which substances fall under PMP monitoring, affecting everything from opioids to stimulants, with implications for prescriber behavior and patient access to legitimate medications

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.